Dr David Barton

Dr. David Barton graduated, with honors, from the Royal College of Surgeons in 2006, before completing his first two years of basic medical training at Beaumont Hospital, Dublin. He then moved to Boston where he completed Internal medicine residency at the Lahey Clinic Medical Center in addition to obtaining American Board certification in Internal Medicine. For the next two years, he returned to Ireland where, among other clinical activities, completed a clinical research fellowship in Cardiology at St. Vincent’s and St. Michael’s hospitals.

Dr. Barton then returned to the US, this time to University of Nebraska Medical Center (UNMC) in Omaha, where he completed his general cardiology fellowship training and subsequently obtained American board of internal medicine certification in cardiovascular medicine. This was followed by an additional year of subspecialty training in Interventional and Structural heart disease and completion of his interventional cardiovascular board certification also. While there, Dr. Barton also achieved level 2 accreditation in heart failure, advanced heart failure therapies and transplantation, echocardiography and cardiac CT. There at UNMC, he continued his academic career as an assistant professor of cardiovascular medicine, where clinically he served as an attending in interventional and structural cardiology. In addition, he held the roles of associate program director of the interventional cardiology fellowship program and as associate director of the heart and vascular clinical research office.

He remains an adjunctive assistant professor of cardiovascular medicine at the University of Nebraska with whom he maintains a collaborative research relationship that focuses on valvular and structural heart disease, contrast echocardiography, mechanical circulatory support and coronary microvascular disease.

Dr. Barton’s areas of clinical interest and expertise lie in preventative cardiology – including hypertension, hypercholesterolemia and lifestyle modification, coronary artery disease including complex coronary interventions (chronic total occlusions and high-risk interventions) and structural heart disease: specifically TAVI and Mitraclip.